Anthocyanins Inhibit Nuclear Factor-B 31/05/2010
Multiple effects of anthocyanins inhibiting influenza (flu) virus infectivity 31/05/2010
Cardiovascular study on Medox and cholesterol and CETP 31/05/2010
Since 2001, Biolink Group has been doing clinical studies on its professional nutrition supplement product Medox®. Clinical studies has taken place at university hospitals and universities in both Norway, EU, Asia and USA. Medox® is now a very well clinic documented product being approved for the Norwegian, Swedish and US-market. In the later years, research has also taken place on Biolink Groups syntheziced antocyanin molecules that makes the platform for the pharmaceutical medicine development.
The clinic research of Biolink Group is taking place at universities and university hospitals in Norway, EU, Asia and USA.
Among the academic institutions doing research together with Biolink Group are:
The University in Bergen, Norway
Different basic medical research departments at Ullevål University Hospital, Oslo, Norway
The University of Oslo, Norway
Rikshospitalet, Oslo, Norway
The University Hospital in Stavanger, Norway
The University Hospital Karolinska Sjukhuset, Stockholm, Sweden
Sun Yat-sen University, Guangzhou, Peoples Republic of China
Summa Health Center, Cleveland, Ohio, USA
Biolink Group are also doing limited research together with different medical researchers.